Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Interventional × Lamivudine × Clear all

Phase

Status

Unknown 5 Completed 3 Recruiting 2 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

pembrolizumab 392 Carboplatin 279 Cyclophosphamide 269 Nivolumab 266 Paclitaxel 225 Cisplatin 217 Specimen Handling 214 Magnetic Resonance Spectroscopy 212 Radiotherapy 188 Dexamethasone 163 Gemcitabine 162 durvalumab 159 Biopsy 151 atezolizumab 136 Lenalidomide 130 Doxorubicin 124 Rituximab 122 Bevacizumab 121 Docetaxel 118 Ipilimumab 116 Oxaliplatin 107 Capecitabine 107 Radiation 104 Fluorouracil 104 fludarabine 99 Radiosurgery 99 Etoposide 99 Pemetrexed 96 Prednisone 95 venetoclax 94

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06494579 2025-12-16

Lamivudine for Solid Tumors

Icahn School of Medicine at Mount Sinai

Phase 1/2 Active not recruiting

Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡